Triple Negative Breast Cancer Biomarker Study
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|Triple Negative Breast Cancer
Sponsor: US Oncology Research
Collaborators: Translational Drug Development|Life Technologies, Inc.